ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma.

导出 OA

翻译打印收藏纠错

作者： Ze,Zhang ^[1] ; Ruoyan,Liu ^[2] ; Yanjie,Shuai ^[1] ; Yuting,Huang ^[3] ; Rui,Jin ^[1] ; Xudong,Wang ^[1] ; Jingtao,Luo ^[4]

作者单位： Department of Maxillofacial and Otorhinolaryngology Oncology and Department of Head and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. ^[1] Department of Gynecologic Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. ^[2] Cancer and Immunology, Children's Research Institute, Children's National Medical Center, Washington, DC, 20010, USA. ^[3] Department of Maxillofacial and Otorhinolaryngology Oncology and Department of Head and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. jluo@tmu.edu.cn. ^[4]